| 1 |
32130375 | Flucloxacillin-Induced Hepatotoxicity - Association with HLA-B*5701. | 2020 |
2 |
| 2 |
32726429 | Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and Presentation. | 2020 Oct 1 |
4 |
| 3 |
30661239 | Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles. | 2019 Jul |
1 |
| 4 |
29436218 | Application of in Vitro T Cell Assay Using Human Leukocyte Antigen-Typed Healthy Donors for the Assessment of Drug Immunogenicity. | 2018 Mar 19 |
2 |
| 5 |
30538582 | Clinical factors predicting drug-induced liver injury due to flucloxacillin. | 2018 |
1 |
| 6 |
28017537 | Human leukocyte antigen and idiosyncratic adverse drug reactions. | 2017 Feb |
3 |
| 7 |
28253087 | Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation. | 2017 Mar |
1 |
| 8 |
28346841 | Rapid and Reliable Genotyping of HLA-B*57:01 in Four Chinese Populations Using a Single-Tube Duplex Real-Time Polymerase Chain Reaction Assay. | 2017 Jul |
2 |
| 9 |
28856081 | Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis? | 2017 |
1 |
| 10 |
27637899 | Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity. | 2016 Dec |
2 |
| 11 |
24777842 | Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review. | 2015 Jun |
1 |
| 12 |
24731753 | T cells infiltrate the liver and kill hepatocytes in HLA-B(∗)57:01-associated floxacillin-induced liver injury. | 2014 Jun |
2 |
| 13 |
25080918 | [Pharmacogenetic research in the association between human leukocyte antigen and adverse drug reactions]. | 2014 Jul |
1 |
| 14 |
22987284 | Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury. | 2013 Feb |
6 |
| 15 |
23032409 | The safety of flucloxacillin in HIV-infected patients with positive HLA-B*5701 genotype. | 2013 Jan 28 |
3 |
| 16 |
23596311 | HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin. | 2013 May 15 |
1 |
| 17 |
21501118 | Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity. | 2011 Jul |
1 |
| 18 |
19483685 | HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. | 2009 Jul |
2 |